National HealthCare Corporation (NHC) स्टॉक विश्लेषण

कंपनी का अवलोकन

National HealthCare Corporation (NHC) is a major operator within the healthcare sector, specifically functioning in the Medical Care Facilities industry by providing essential services to skilled nursing facilities, assisted and independent living facilities, homecare, hospice agencies, and health hospitals. The organization executes its operations through two distinct segments focused on Inpatient care and Homecare and Hospice Services, thereby addressing critical needs across the continuum of patient care. This entity maintains a substantial scale with a total market capitalization of $2.76 billion and an annual revenue base of $1.52 billion, supported by a workforce of 15,278 employees. These valuation and revenue figures indicate that the company occupies a significant position within the market, reflecting a large operational footprint and a robust revenue generation capability that sustains its extensive network of care facilities.

वित्तीय स्वास्थ्य

The financial performance of the company is characterized by a Trailing Twelve Months (TTM) revenue of $1.52 billion, a net income of $120.02 million, and an EBITDA of $173.27 million. The substantial gap between the total revenue and the net income reveals a cost structure where operating expenses, including cost of goods sold and administrative costs, consume a significant portion of top-line earnings before arriving at the bottom line. The company generated $108.38 million in free cash flow, which signifies strong financial flexibility allowing for potential capital expenditures, debt repayment, or reinvestment into the healthcare infrastructure without immediate reliance on external financing. Profitability metrics show a gross margin of 39.3%, an operating margin of 8.6%, and a profit margin of 7.9%, indicating that while the company maintains healthy pricing power in its services, overhead costs and other expenses impact the final profitability relative to total sales. On the balance sheet, the company holds $255.80 million in cash against $87.07 million in debt, supported by a debt-to-equity ratio of 8.10, suggesting a balance sheet that is leveraged but manages its obligations with a significant cash buffer. Short-term liquidity is robust as evidenced by a current ratio of 1.82, indicating that the company possesses ample current assets to cover its current liabilities comfortably. Management effectiveness is highlighted by a return on equity of 11.9% and a return on assets of 5.3%, which demonstrate the company's ability to generate returns on shareholder capital and utilize its asset base efficiently.

मूल्यांकन आकलन

Valuation multiples for National HealthCare Corporation show a P/E Ratio (TTM) of 23.05 contrasted with a Forward P/E of 411.19, implying that the market currently prices in significantly higher expected earnings growth than what has been realized historically. The extreme disparity between the trailing and forward P/E suggests that market expectations for future earnings expansion are exceptionally high or that current earnings may be subject to one-time adjustments affecting the TTM figure. The price-to-book ratio stands at 2.57, indicating that the stock trades at a premium of roughly 157% over its book value, reflecting investor confidence in the quality of the company's assets and intangible brand value in the healthcare sector. Alternative valuation metrics include a price-to-sales ratio of 1.82 and an EV/EBITDA of 14.92, which suggest the company is valued at a premium relative to its sales but maintains a reasonable multiple relative to its earnings before interest, taxes, depreciation, and amortization. Regarding price volatility, the stock has a beta of 0.59 and a 52-week trading range between $89.14 and $177.39, meaning the stock is currently trading within its historical range but exhibits lower volatility relative to the broader market index.

Growth & Income

Growth dynamics for the company include a revenue growth rate of 4.6% year-over-year and an earnings growth rate of 306.3% year-over-year, indicating that earnings are expanding at a pace vastly exceeding revenue growth, likely due to margin expansion or non-recurring income items. The company pays a dividend with a yield of 1.4% and a payout ratio of 33.0%, which suggests that the dividend coverage is highly sustainable given the earnings growth and the low proportion of earnings allocated to dividend distribution. This low payout ratio allows the firm to retain a majority of its profits for reinvestment in facilities and operational improvements rather than distributing the bulk of earnings to shareholders. Overall, the profile presents a blend of moderate revenue expansion, explosive earnings growth, and a conservative dividend policy that prioritizes financial stability and internal growth over high shareholder cash distributions.